Anna Eshoo actually said...

"Congress does need to review and better understand drug pricing to ensure that we are incentivizing research and innovation and development of new drug treatments and cures without creating loopholes ..."

"Because of the leadership of this committee, CMS has announced a plan change to that as of January 1."

"We need an approach that focuses on the patient and the cost to the health care system, which will be tethered by ensuring that there is sufficient competition in the market place."

"It would be nice if we could come up with a simplified system for drug pricing and perhaps this hearing will begin that."